MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information
Journal of Chemical Information and Modeling · 08.04.2024 · 64 (7) · 2331-2344
DOI: 10.1021/acs.jcim.3c00799 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 29.08.2023. Verfasst von Wouter Heyndrickx und 48 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium. Hauptthemen laut MEDLINE: Quantitative Structure-Activity Relationship. Die Arbeit wurde bisher 165-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: KU Leuven, Innovative Medicines Initiative, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium.
- AstraZeneca R&D, Biomedical Campus, 1 Francis Crick Ave, Cambridge CB2 0SL, U.K.
- Bayer Pharma AG, Global Drug Discovery, Chemical Research, Computational Chemistry, Aprather Weg 18 a, Wuppertal 42096, Germany.
- Novartis Institutes for BioMedical Research, Novartis Campus, Basel 4002, Switzerland.
- Merck KGaA, Global Research & Development, Frankfurter Strasse 250, Darmstadt 64293, Germany.
- Amgen Research (Munich) GmbH, Staffelseestraße 2, Munich 81477, Germany.
ORCID-Profile: Wouter Heyndrickx, Lewis Mervin, Martijn Oldenhof, Nikolas Fechner, Nicholas Holway, Peter Ertl, Hideyoshi Fuji, Stephen Pickett, Friedrich Rippmann, Ola Engkvist, Andreas H Göller, Ansgar Schuffenhauer
Förderung
- KU Leuven
- Innovative Medicines Initiative
- Horizon 2020 Framework Programme
- European Federation of Pharmaceutical Industries and Associations
Zitieren
APA
Heyndrickx, W., Mervin, L., Morawietz, T., Sturm, N., Friedrich, L., Zalewski, A., Pentina, A., Humbeck, L., Oldenhof, M., Niwayama, R., Schmidtke, P., Fechner, N., Simm, J., Arany, A., Drizard, N., Jabal, R., Afanasyeva, A., Loeb, R., Verma, S., …, & Ceulemans, H. (2024). MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information. Journal of Chemical Information and Modeling, 64(7), 2331-2344. https://doi.org/10.1021/acs.jcim.3c00799
Vancouver
Heyndrickx W, Mervin L, Morawietz T, Sturm N, Friedrich L, Zalewski A, et al. MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information. Journal of Chemical Information and Modeling. 2024;64(7):2331-2344. doi:10.1021/acs.jcim.3c00799
BibTeX
@article{Heyndrickx2024,
author = {Heyndrickx, Wouter and Mervin, Lewis and Morawietz, Tobias and Sturm, Noé and Friedrich, Lukas and Zalewski, Adam and Pentina, Anastasia and Humbeck, Lina and Oldenhof, Martijn and Niwayama, Ritsuya and Schmidtke, Peter and Fechner, Nikolas and Simm, Jaak and Arany, Adam and Drizard, Nicolas and Jabal, Rama and Afanasyeva, Arina and Loeb, Regis and Verma, Shlok and Harnqvist, Simon and Holmes, Matthew and Pejo, Balazs and Telenczuk, Maria and Holway, Nicholas and Dieckmann, Arne and Rieke, Nicola and Zumsande, Friederike and Clevert, Djork-Arné and Krug, Michael and Luscombe, Christopher and Green, Darren and Ertl, Peter and Antal, Peter and Marcus, David and Do Huu, Nicolas and Fuji, Hideyoshi and Pickett, Stephen and Acs, Gergely and Boniface, Eric and Beck, Bernd and Sun, Yax and Gohier, Arnaud and Rippmann, Friedrich and Engkvist, Ola and Göller, Andreas H and Moreau, Yves and Galtier, Mathieu N and Schuffenhauer, Ansgar and Ceulemans, Hugo},
title = {MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information},
journal = {Journal of Chemical Information and Modeling},
year = {2024},
volume = {64},
number = {7},
pages = {2331--2344},
doi = {10.1021/acs.jcim.3c00799}
}
EUVIMED